Chemed Corporation
CHE
$595.74
$1.390.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.43B | 2.38B | 2.34B | 2.29B | 2.26B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.43B | 2.38B | 2.34B | 2.29B | 2.26B |
| Cost of Revenue | 1.58B | 1.53B | 1.50B | 1.48B | 1.47B |
| Gross Profit | 854.35M | 847.80M | 839.98M | 813.47M | 798.82M |
| SG&A Expenses | 424.36M | 420.55M | 418.17M | 410.90M | 395.12M |
| Depreciation & Amortization | 63.05M | 62.76M | 62.44M | 61.87M | 60.87M |
| Other Operating Expenses | 0.00 | -1.78M | -1.59M | -1.65M | 0.00 |
| Total Operating Expenses | 2.06B | 2.01B | 1.97B | 1.95B | 1.92B |
| Operating Income | 366.94M | 366.27M | 360.96M | 342.34M | 342.83M |
| Income Before Tax | 399.47M | 394.94M | 387.17M | 363.69M | 350.37M |
| Income Tax Expenses | 97.47M | 93.20M | 86.26M | 80.28M | 77.86M |
| Earnings from Continuing Operations | 302.00 | 301.73 | 300.92 | 283.41 | 272.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 302.00M | 301.73M | 300.92M | 283.41M | 272.51M |
| EBIT | 366.94M | 366.27M | 360.96M | 342.34M | 342.83M |
| EBITDA | 425.69M | 424.53M | 418.90M | 399.72M | 399.20M |
| EPS Basic | 20.12 | 20.00 | 19.93 | 18.78 | 18.10 |
| Normalized Basic EPS | 16.65 | 16.46 | 16.12 | 15.16 | 14.64 |
| EPS Diluted | 19.92 | 19.79 | 19.72 | 18.58 | 17.92 |
| Normalized Diluted EPS | 16.48 | 16.27 | 15.95 | 14.99 | 14.49 |
| Average Basic Shares Outstanding | 60.10M | 60.34M | 60.39M | 60.35M | 60.20M |
| Average Diluted Shares Outstanding | 60.75M | 61.03M | 61.06M | 61.03M | 60.80M |
| Dividend Per Share | 1.80 | 1.70 | 1.60 | 1.58 | 1.56 |
| Payout Ratio | 8.97% | 8.50% | 8.04% | 8.42% | 8.62% |
